RecruitingISRCTN11847322
This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom.
In United KingdomSchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United Kingdom
- Sponsor
- University of Manchester
- Condition
- Schizophrenia
RecruitingISRCTN95702682
This study is recruiting in the United Kingdom. It focuses on schizophrenia.
In United KingdomBipolarity, SchizophreniaOtherFrom 18 Years to 110 Years
- Countries
- United Kingdom
- Sponsor
- Birmingham and Solihull Mental Health Foundation Trust
- Condition
- Bipolarity, Schizophrenia
RecruitingNCT05340348
This study is recruiting. It focuses on schizophrenia and currently lists participation information in France.
In BrestSchizophreniaOtherFrom 15 Years to 30 Years
- Countries
- France
- Sponsor
- University Hospital, Brest
- Condition
- Schizophrenia
RecruitingNCT07176468
This study is recruiting. It focuses on schizophrenia and currently lists participation information in China.
In HefeiSchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- China
- Sponsor
- Anhui Medical University
- Condition
- Schizophrenia
RecruitingNCT07185815
This study is recruiting in India and in Israel. It focuses on Depression.
Multiple locations, including AhmedabadDepression, Schizophrenia, ...DrugA study involving a medication or substance.From 18 Years to 64 Years
- Countries
- India, Israel
- Sponsor
- Mapi Pharma Ltd.
- Condition
- Depression, Schizophrenia, ...
RecruitingISRCTN36607067
This study is recruiting. It focuses on depression and currently lists participation information in the Netherlands.
In NetherlandsDepression, SchizophreniaOtherOver 18 Years
- Countries
- Netherlands
- Sponsor
- University Medical Center Utrecht (UMCU) (The Netherlands)
- Condition
- Depression, Schizophrenia
RecruitingNCT07029581
This study is recruiting in the United States, in France, in Bulgaria, .... It is testing ACP-204 for Schizophrenia.
Multiple locations, including IrvineSchizophreniaDrugFrom 55 Years to 84 Years
- Countries
- United States, France, Bulgaria, ...
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Condition
- Schizophrenia
RecruitingISRCTN97049967
This study is recruiting in the United Kingdom, in Argentina, in Brazil, .... It is testing lurasidone for schizophrenia.
In United KingdomSchizophreniaOtherFrom 18 Years to 75 Years
- Countries
- United Kingdom, Argentina, Brazil, ...
- Sponsor
- Dainippon Sumitomo Pharma America Inc. (USA)
- Condition
- Schizophrenia
RecruitingISRCTN17586238
This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom.
In United KingdomSchizophreniaOtherFrom 18 Years to 120 Years
- Countries
- United Kingdom
- Sponsor
- Queen Mary University of London
- Condition
- Schizophrenia
RecruitingNCT04889911
This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.
In IndianapolisSchizophreniaBehavioralFrom 15 Years to 24 Years
- Countries
- United States
- Sponsor
- John Jay College of Criminal Justice, City University of New York
- Condition
- Schizophrenia
RecruitingISRCTN93378085
This study is recruiting in the United Kingdom. It focuses on schizophrenia.
In United KingdomSchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United Kingdom
- Sponsor
- Record Provided by the NHSTCT Register - 2007 Update - Department of Health
- Condition
- Schizophrenia
RecruitingISRCTN16328317
This study is recruiting in Germany. It focuses on depression.
In GermanyDepression, Anxiety, ...OtherFrom 18 Years to 65 Years
- Countries
- Germany
- Sponsor
- Heinrich Heine University Düsseldorf
- Condition
- Depression, Anxiety, ...
